These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9872413)

  • 1. The role of the cysteine-rich region of the beta2 integrin subunit in the leukocyte function-associated antigen-1 (LFA-1, alphaLbeta2, CD11a/CD18) heterodimer formation and ligand binding.
    Douglass WA; Hyland RH; Buckley CD; Al-Shamkhani A; Shaw JM; Scarth SL; Simmons DL; Law SK
    FEBS Lett; 1998 Dec; 440(3):414-8. PubMed ID: 9872413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of integrin beta 2 subunit truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) assembly, surface expression, and function.
    Tan SM; Hyland RH; Al-Shamkhani A; Douglass WA; Shaw JM; Law SK
    J Immunol; 2000 Sep; 165(5):2574-81. PubMed ID: 10946284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of I domain deletion on the function of the beta2 integrin lymphocyte function-associated antigen-1.
    Leitinger B; Hogg N
    Mol Biol Cell; 2000 Feb; 11(2):677-90. PubMed ID: 10679023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeras of the integrin beta subunit mid-region reveal regions required for heterodimer formation and for activation.
    Hyland RH; Douglass WA; Tan SM; Law SK
    Cell Commun Adhes; 2001; 8(2):61-9. PubMed ID: 11771726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding.
    Huth JR; Olejniczak ET; Mendoza R; Liang H; Harris EA; Lupher ML; Wilson AE; Fesik SW; Staunton DE
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5231-6. PubMed ID: 10805782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique CD18 mutations involving a deletion in the extracellular stalk region and a major truncation of the cytoplasmic domain in a patient with leukocyte adhesion deficiency type 1.
    Hixson P; Smith CW; Shurin SB; Tosi MF
    Blood; 2004 Feb; 103(3):1105-13. PubMed ID: 14512306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific activation of leukocyte beta2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the alpha subunit cytoplasmic domains.
    Weber KS; Klickstein LB; Weber C
    Mol Biol Cell; 1999 Apr; 10(4):861-73. PubMed ID: 10198043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The I domain of integrin leukocyte function-associated antigen-1 is involved in a conformational change leading to high affinity binding to ligand intercellular adhesion molecule 1 (ICAM-1).
    McDowall A; Leitinger B; Stanley P; Bates PA; Randi AM; Hogg N
    J Biol Chem; 1998 Oct; 273(42):27396-403. PubMed ID: 9765268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binding sites for competitive antagonistic, allosteric antagonistic, and agonistic antibodies to the I domain of integrin LFA-1.
    Lu C; Shimaoka M; Salas A; Springer TA
    J Immunol; 2004 Sep; 173(6):3972-8. PubMed ID: 15356146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of amino acids in the CD11a I-domain important for binding of the leukocyte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule-1 (ICAM-1).
    Edwards CP; Champe M; Gonzalez T; Wessinger ME; Spencer SA; Presta LG; Berman PW; Bodary SC
    J Biol Chem; 1995 May; 270(21):12635-40. PubMed ID: 7539005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the CPNKEKEC sequence in the beta(2) subunit I domain in regulation of integrin alpha(L)beta(2) (LFA-1).
    Kamata T; Tieu KK; Tarui T; Puzon-McLaughlin W; Hogg N; Takada Y
    J Immunol; 2002 Mar; 168(5):2296-301. PubMed ID: 11859118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1.
    Béchard D; Scherpereel A; Hammad H; Gentina T; Tsicopoulos A; Aumercier M; Pestel J; Dessaint JP; Tonnel AB; Lassalle P
    J Immunol; 2001 Sep; 167(6):3099-106. PubMed ID: 11544294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of CD11a/CD18, CD11b/CD18, ICAM-1 (CD54) and -2 (CD102) to human monocyte migration through endothelium and connective tissue fibroblast barriers.
    Shang XZ; Issekutz AC
    Eur J Immunol; 1998 Jun; 28(6):1970-9. PubMed ID: 9645379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of LFA-1 (CD11a/CD18) cytoplasmic domains in binding to intercellular adhesion molecule-1 (CD54) and in postreceptor cell spreading.
    Pyszniak AM; Carpenito C; Takei F
    Exp Cell Res; 1997 May; 233(1):78-87. PubMed ID: 9184078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of the LFA-1 integrin beta2-chain on Thr-758 leads to adhesion, Rac-1/Cdc42 activation, and stimulation of CD69 expression in human T cells.
    Nurmi SM; Autero M; Raunio AK; Gahmberg CG; Fagerholm SC
    J Biol Chem; 2007 Jan; 282(2):968-75. PubMed ID: 17107954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A binding interface on the I domain of lymphocyte function-associated antigen-1 (LFA-1) required for specific interaction with intercellular adhesion molecule 1 (ICAM-1).
    Huang C; Springer TA
    J Biol Chem; 1995 Aug; 270(32):19008-16. PubMed ID: 7642561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-terminal region and the mid-region complex of the integrin beta 2 subunit.
    Tan SM; Robinson MK; Drbal K; van Kooyk Y; Shaw JM; Law SK
    J Biol Chem; 2001 Sep; 276(39):36370-6. PubMed ID: 11477072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of four CD18 mutants in leucocyte adhesion deficient (LAD) patients with differential capacities to support expression and function of the CD11/CD18 integrins LFA-1, Mac-1 and p150,95.
    Shaw JM; Al-Shamkhani A; Boxer LA; Buckley CD; Dodds AW; Klein N; Nolan SM; Roberts I; Roos D; Scarth SL; Simmons DL; Tan SM; Law SK
    Clin Exp Immunol; 2001 Nov; 126(2):311-8. PubMed ID: 11703376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition and stimulation of LFA-1 and Mac-1 functions by antibodies against murine CD18. Evidence that the LFA-1 binding sites for ICAM-1, -2, and -3 are distinct.
    Driessens MH; van Hulten P; Zuurbier A; La Rivière G; Roos E
    J Leukoc Biol; 1996 Dec; 60(6):758-65. PubMed ID: 8975879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD18 activation epitopes induced by leukocyte activation.
    Beals CR; Edwards AC; Gottschalk RJ; Kuijpers TW; Staunton DE
    J Immunol; 2001 Dec; 167(11):6113-22. PubMed ID: 11714770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.